145 related articles for article (PubMed ID: 25610744)
1. Innate γδT17 cells convert cancer-elicited inflammation into immunosuppression through myeloid-derived suppressor cells.
Yan J; Huang J
Oncoimmunology; 2014; 3(8):e953423. PubMed ID: 25610744
[TBL] [Abstract][Full Text] [Related]
2. γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer.
Wu P; Wu D; Ni C; Ye J; Chen W; Hu G; Wang Z; Wang C; Zhang Z; Xia W; Chen Z; Wang K; Zhang T; Xu J; Han Y; Zhang T; Wu X; Wang J; Gong W; Zheng S; Qiu F; Yan J; Huang J
Immunity; 2014 May; 40(5):785-800. PubMed ID: 24816404
[TBL] [Abstract][Full Text] [Related]
3. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.
Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D
Front Immunol; 2019; 10():475. PubMed ID: 30936876
[TBL] [Abstract][Full Text] [Related]
4. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
5. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
Draghiciu O; Lubbers J; Nijman HW; Daemen T
Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
[TBL] [Abstract][Full Text] [Related]
6. Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1
Sun X; Cai Y; Fleming C; Tong Z; Wang Z; Ding C; Qu M; Zhang HG; Suo J; Yan J
Oncoimmunology; 2017; 6(5):e1313369. PubMed ID: 28638741
[TBL] [Abstract][Full Text] [Related]
7. Phenotype, development, and biological function of myeloid-derived suppressor cells.
Zhao Y; Wu T; Shao S; Shi B; Zhao Y
Oncoimmunology; 2016 Feb; 5(2):e1004983. PubMed ID: 27057424
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell defects in the colorectal cancer.
Legitimo A; Consolini R; Failli A; Orsini G; Spisni R
Hum Vaccin Immunother; 2014; 10(11):3224-35. PubMed ID: 25483675
[TBL] [Abstract][Full Text] [Related]
9. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
[TBL] [Abstract][Full Text] [Related]
10. Exosomes Derived From Dendritic Cells Infected With
Lu J; Wei N; Zhu S; Chen X; Gong H; Mi R; Huang Y; Chen Z; Li G
Front Oncol; 2022; 12():899737. PubMed ID: 35600363
[TBL] [Abstract][Full Text] [Related]
11. Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.
Lin Y; Yang X; Liu W; Li B; Yin W; Shi Y; He R
Oncogene; 2017 Jun; 36(25):3599-3608. PubMed ID: 28166197
[TBL] [Abstract][Full Text] [Related]
12. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
Fernández A; Oliver L; Alvarez R; Fernández LE; Lee KP; Mesa C
Hum Vaccin Immunother; 2014; 10(11):3251-60. PubMed ID: 25483674
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
Eksioglu EA; Mahmood SS; Chang M; Reddy V
Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
Front Immunol; 2019; 10():183. PubMed ID: 30863394
[TBL] [Abstract][Full Text] [Related]
15. Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF.
Oghiso Y; Yamada Y; Ando K; Ishihara H; Shibata Y
J Leukoc Biol; 1993 Jan; 53(1):86-92. PubMed ID: 7678847
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostaglandin E2 (PGE2) on IL-3/granulocyte-macrophage colony-stimulating factor production by T helper cells. Mode of stimulation and presence of costimulation can determine response to PGE2.
Li TK; Fox BS
J Immunol; 1993 Mar; 150(5):1680-90. PubMed ID: 8436811
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Mll1-Complex by Stat3/Cebpβ-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells.
Zhang Z; Huang X; Wang E; Huang Y; Yang R
J Immunol; 2020 Jun; 204(12):3400-3415. PubMed ID: 32358019
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.
Menetrier-Caux C; Montmain G; Dieu MC; Bain C; Favrot MC; Caux C; Blay JY
Blood; 1998 Dec; 92(12):4778-91. PubMed ID: 9845545
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.
Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA
Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
Tamadaho RSE; Hoerauf A; Layland LE
Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
